Clinical efficacy of dual inhibitor of neprilisin and AT1‑angiotensin receptors LCZ696 (sakubitril/valsartan) in chronic heart failure patients with impaired renal function

2017 ◽  
Vol 17 (3) ◽  
pp. 233-240
Author(s):  
O. B. Kuzmin ◽  
◽  
V. V. Zezha ◽  
V. V. Belyanin ◽  
N. V. Buchneva ◽  
...  
2004 ◽  
Vol 148 (1) ◽  
pp. 165-172 ◽  
Author(s):  
Tom D.J. Smilde ◽  
Hans L. Hillege ◽  
Gerjan Navis ◽  
Frans Boomsma ◽  
Dick de Zeeuw ◽  
...  

2009 ◽  
Vol 11 (9) ◽  
pp. 872-880 ◽  
Author(s):  
Alain Cohen-Solal ◽  
Dipak Kotecha ◽  
Dirk J van Veldhuisen ◽  
Daphne Babalis ◽  
Michael Böhm ◽  
...  

2020 ◽  
Vol 16 (3) ◽  
pp. 159-164
Author(s):  
Julien Regamey ◽  
Nicolas Barras ◽  
Marco Rusca ◽  
Roger Hullin

Outcomes in acute decompensated heart failure remain poor, in particular when patients present with impaired renal function. Recent results indicate that treatment of acute decompensated heart failure patients with the Reitan catheter pump not only increases cardiac index, but also improves renal function resulting in maintained increase of diuresis. These favorable effects were achieved without significant hemolysis, bleeding or vascular complications suggesting that Reitan catheter pump treatment has the potential to facilitate recovery from acute decompensated heart failure with low output and complicated by renal dysfunction.


2018 ◽  
Vol 93 (4) ◽  
pp. 952-960 ◽  
Author(s):  
Milos Brankovic ◽  
K. Martijn Akkerhuis ◽  
Nick van Boven ◽  
Sharda Anroedh ◽  
Alina Constantinescu ◽  
...  

2010 ◽  
Vol 12 (2) ◽  
pp. 122-128 ◽  
Author(s):  
Amalia Vaz Pérez ◽  
Katrin Otawa ◽  
Arabel V. Zimmermann ◽  
Martin Stockburger ◽  
Ursula Müller-Werdan ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document